Cargando…

Dose Escalation of Lobaplatin Concurrent with IMRT for the Treatment of Stage III-IVb NPC: A Phase I Clinical Trial()()

The maximum tolerated dose (MTD) of lobaplatin as a single agent chemotherapy concurrent with intensity-modulated radiotherapy (IMRT) in Asian population with nasopharyngeal carcinoma (NPC) remains unclear. From June 2016 to December 2017, 17 patients diagnosed with stage III-IVb NPC from an Asian p...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Si-Yang, Xu, Xi-Wei, Yao, Ji-Jin, Peng, Pei-Jian, Zhou, Bin, Liu, Qiao-Dan, Huang, Xiao-Ping, Lin, Zhong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Neoplasia Press 2018
Materias:	Original article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6039884/ https://www.ncbi.nlm.nih.gov/pubmed/29966863 http://dx.doi.org/10.1016/j.tranon.2018.06.004

Ejemplares similares

Dose-escalation by hypofractionated simultaneous integrated boost IMRT in unresectable stage III non-small-cell lung cancer
por: Zhang, Qin, et al.
Publicado: (2022)

The long-term survival of patients with III-IVb stage nasopharyngeal carcinoma treated with IMRT with or without Nimotuzumab: a propensity score-matched analysis
por: Zhi-Qiang, Wang, et al.
Publicado: (2019)

Adding Concurrent Chemotherapy Significantly Improves the Survival of Stage II-IVb Nasopharyngeal Carcinoma Patients Treated With Concurrent Anti-EGFR Agents
por: Yu, Zi-Kun, et al.
Publicado: (2021)

Prospective Evaluation of Probabilistic Dose-escalated IMRT in Prostate Cancer
por: Wegener, Daniel, et al.
Publicado: (2020)

A phase II trial of preoperative concurrent chemotherapy and dose escalated intensity modulated radiotherapy (IMRT) for locally advanced rectal cancer
por: Tey, Jeremy, et al.
Publicado: (2017)

Prospective evaluation of dose-escalated preoperative concurrent chemo-radiation with image guided-IMRT in locally advanced rectal cancers
por: Puri, Raunaq, et al.
Publicado: (2023)

NACT+IMRT versus NACT+IMRT+CCRT in locoregionally advanced NPC patients: a retrospective study
por: Chen, Xialin, et al.
Publicado: (2019)

A phase I clinical trial of dose escalation of lobaplatin in combination with fixed-dose docetaxel for the treatment of human solid tumours that had progressed following chemotherapy
por: PENG, YU, et al.
Publicado: (2015)

Dose escalation study of proton beam therapy with concurrent chemotherapy for stage III non‐small cell lung cancer
por: Harada, Hideyuki, et al.
Publicado: (2016)

Phase III study of cisplatin with or without S-1 in patients with stage IVB, recurrent, or persistent cervical cancer
por: Aoki, Yoichi, et al.
Publicado: (2018)

Hematological Toxicities of Concurrent Chemoradiotherapies in Head and Neck Cancers: Comparison Among Cisplatin, Nedaplatin, Lobaplatin, and Nimotuzumab
por: Wu, Qiuji, et al.
Publicado: (2021)

Concurrent chemoradiotherapy with or without cetuximab for stage II to IVb nasopharyngeal carcinoma: a case–control study
por: Li, Yang, et al.
Publicado: (2017)

Induction chemotherapy followed by concurrent chemoradiotherapy versus concurrent chemoradiotherapy alone in stage III-IVb nasopharyngeal carcinoma patients with Epstein-Barr virus DNA ≥4000 copies/ml: a matched study
por: Guo, Shan-Shan, et al.
Publicado: (2016)

Exploration and validation of radiomics signature as an independent prognostic biomarker in stage III-IVb nasopharyngeal carcinoma
por: Ouyang, Fu-Sheng, et al.
Publicado: (2017)

IMRT combined with concurrent chemotherapy plus adjuvant chemotherapy versus IMRT combined with concurrent chemotherapy alone in patients with nasopharyngeal carcinoma
por: Zhong, Qiulu, et al.
Publicado: (2017)

Phycomyces: irregular growth patterns in stage IVb sporangiophores
Publicado: (1981)

Lobaplatin: Multiple toxicities: case report.
Publicado: (2020)

Dose-escalation study of weekly irinotecan and daily carboplatin with concurrent thoracic radiotherapy for unresectable stage III non-small cell lung cancer
por: Yamada, M, et al.
Publicado: (2002)

Radiation Dose Escalation in Stage III Non-Small-Cell Lung Cancer
por: Terakedis, Breanne, et al.
Publicado: (2011)

Dose escalation with an IMRT technique in 15 to 28 fractions is better tolerated than standard doses of 3DCRT for LAPC
por: Colbert, Lauren E., et al.
Publicado: (2017)

Longitudinal Trend of Health-Related Quality of Life During Concurrent Chemoradiotherapy and Survival in Patients With Stage II–IVb Nasopharyngeal Carcinoma
por: Li, Ji-Bin, et al.
Publicado: (2020)

Clinicopathologic characteristics and survival analysis in stage IVB cervical cancer with hematogenous metastasis
por: Li, Haoran, et al.
Publicado: (2019)

Induction chemotherapy with albumin-bound paclitaxel plus lobaplatin followed by concurrent radiochemotherapy for locally advanced esophageal cancer
por: Yan, Mao-Hui, et al.
Publicado: (2021)

Efficacy and toxicity of three concurrent chemoradiotherapy regimens in treating nasopharyngeal carcinoma: Comparison among cisplatin, nedaplatin, and lobaplatin
por: Liang, Xuexia, et al.
Publicado: (2022)

Paclitaxel liposome, cisplatin and 5-fluorouracil-based induction chemotherapy followed by de-escalated intensity-modulated radiotherapy with concurrent cisplatin in stage IVA–IVB childhood nasopharyngeal carcinoma in endemic area: a phase II, single-arm trial
por: Luo, Dong-Hua, et al.
Publicado: (2023)

Hypoalbuminemia for the prediction of survival in patients with stage IVB cervical cancer
por: Yoshikawa, Nobuhisa, et al.
Publicado: (2022)

A single-institution phase I feasibility study of dose-escalated IMRT for non-operative locally advanced esophageal carcinoma
por: Vlacich, Gregory, et al.
Publicado: (2021)

Nomogram Predicting the Benefits of Adding Concurrent Chemotherapy to Intensity-Modulated Radiotherapy After Induction Chemotherapy in Stages II–IVb Nasopharyngeal Carcinoma
por: Liu, Sai-Lan, et al.
Publicado: (2020)

The Efficacy and Toxicity of Lobaplatin-contained Chemotherapy in Extensive-stage Small-cell Lung Cancer
por: Zhou, Ning-ning, et al.
Publicado: (2018)

Efficacy and safety of PLDR‐IMRT for the re‐irradiation of recurrent NPC: A prospective, single‐arm, multicenter trial
por: Huang, Rui, et al.
Publicado: (2023)

A novel N staging system for NPC based on IMRT and RTOG guidelines for lymph node levels: Results of a prospective multicentric clinical study
por: Kang, Min, et al.
Publicado: (2018)

Phase II and pharmacokinetic study of lobaplatin in patients with relapsed ovarian cancer.
por: Gietema, J. A., et al.
Publicado: (1995)

IDEAL-CRT: A Phase 1/2 Trial of Isotoxic Dose-Escalated Radiation Therapy and Concurrent Chemotherapy in Patients With Stage II/III Non-Small Cell Lung Cancer
por: Landau, David B., et al.
Publicado: (2016)

Strong interaction IVB models
por: Marshak, Robert Eugene, et al.
Publicado: (1969)

Rapidly progressive stage IVB mycosis fungoides treated with low-dose total skin electron beam therapy
por: Chowdhary, Mudit, et al.
Publicado: (2015)

Cetuximab concurrent with IMRT versus cisplatin concurrent with IMRT in locally advanced nasopharyngeal carcinoma: A retrospective matched case–control study
por: Wu, Xin, et al.
Publicado: (2016)

Hyperthermic intraoperative thoracoabdominal chemotherapy for stage IVB epithelial ovarian carcinoma
por: Brind'Amour, Alexandre, et al.
Publicado: (2020)

Optimal Management for Stage IVB Endometrial Cancer: A Systematic Review
por: Capozzi, Vito Andrea, et al.
Publicado: (2023)

Dose escalation in advanced floor of the mouth cancer: a pilot study using a combination of IMRT and stereotactic boost
por: Blažek, Tomáš, et al.
Publicado: (2021)

Impact of Chemoradiation on Prognosis in Stage IVB Cervical Cancer with Distant Lymphatic Metastasis
por: Kim, Hee Seung, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_dlrlvabsduc2r17ltidr8uk4h2